TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com

StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report published on Tuesday morning. The firm issued a hold rating on the stock.

TherapeuticsMD Stock Up 0.6 %

TherapeuticsMD stock opened at $1.59 on Tuesday. The stock has a 50-day moving average price of $1.69 and a 200 day moving average price of $1.82. TherapeuticsMD has a 52 week low of $1.43 and a 52 week high of $3.07.

TherapeuticsMD (NASDAQ:TXMD) last released its quarterly earnings data on Monday, August 12th. The company reported ($0.09) EPS for the quarter. The firm had revenue of $0.23 million for the quarter.

Institutional Trading of TherapeuticsMD

An institutional investor recently bought a new position in TherapeuticsMD stock. Prosperity Consulting Group LLC purchased a new stake in TherapeuticsMD, Inc. (NASDAQ:TXMD) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 24,500 shares of the company’s stock, valued at approximately $56,000. Prosperity Consulting Group LLC owned 0.21% of TherapeuticsMD at the end of the most recent quarter. 30.74% of the stock is currently owned by institutional investors.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.